交易 Medtronic - MDT CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.25 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Medtronic PLC ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Mar 22, 2023 | 79.81 | -0.93 | -1.15% | 80.74 | 81.90 | 79.81 |
Mar 21, 2023 | 81.13 | 1.23 | 1.54% | 79.90 | 81.33 | 79.43 |
Mar 20, 2023 | 79.49 | 0.90 | 1.15% | 78.59 | 79.70 | 78.25 |
Mar 17, 2023 | 78.12 | -1.09 | -1.38% | 79.21 | 79.29 | 77.72 |
Mar 16, 2023 | 79.20 | 2.02 | 2.62% | 77.18 | 79.33 | 77.04 |
Mar 15, 2023 | 78.31 | 1.77 | 2.31% | 76.54 | 78.31 | 76.54 |
Mar 14, 2023 | 77.73 | -1.32 | -1.67% | 79.05 | 79.25 | 76.95 |
Mar 13, 2023 | 77.92 | 1.97 | 2.59% | 75.95 | 78.41 | 75.93 |
Mar 10, 2023 | 76.62 | -1.10 | -1.42% | 77.72 | 78.02 | 76.02 |
Mar 9, 2023 | 77.90 | -0.41 | -0.52% | 78.31 | 79.25 | 77.88 |
Mar 8, 2023 | 78.30 | -1.16 | -1.46% | 79.46 | 79.51 | 77.93 |
Mar 7, 2023 | 79.71 | -2.23 | -2.72% | 81.94 | 82.00 | 79.38 |
Mar 6, 2023 | 81.83 | -1.49 | -1.79% | 83.32 | 83.74 | 81.34 |
Mar 3, 2023 | 83.33 | 1.28 | 1.56% | 82.05 | 83.52 | 82.05 |
Mar 2, 2023 | 82.13 | 0.75 | 0.92% | 81.38 | 82.49 | 81.07 |
Mar 1, 2023 | 81.96 | -0.03 | -0.04% | 81.99 | 82.45 | 81.56 |
Feb 28, 2023 | 82.70 | -0.43 | -0.52% | 83.13 | 83.61 | 82.45 |
Feb 27, 2023 | 83.27 | 0.07 | 0.08% | 83.20 | 84.04 | 82.97 |
Feb 24, 2023 | 83.40 | 0.61 | 0.74% | 82.79 | 83.59 | 82.10 |
Feb 23, 2023 | 83.89 | -0.75 | -0.89% | 84.64 | 84.99 | 83.31 |
Medtronic Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
总收入 | 31686 | 30117 | 28913 | 30557 | 29953 |
收入 | 31686 | 30117 | 28913 | 30557 | 29953 |
收入成本,共计 | 9971 | 10355 | 9269 | 9064 | 9039 |
毛利 | 21715 | 19762 | 19644 | 21493 | 20914 |
总营业费用 | 25934 | 25941 | 24535 | 24774 | 23351 |
销售/一般/行政费用,总计 | 10135 | 9776 | 9875 | 10232 | 9953 |
研究与开发 | 2746 | 2493 | 2331 | 2330 | 2256 |
Depreciation / Amortization | 1733 | 1783 | 1756 | 1764 | 1823 |
利息费用(收入) - 净运营 | -117 | -224 | 226 | ||
异常费用(收入) | 1154 | 1219 | 1303 | 1342 | -172 |
Other Operating Expenses, Total | 195 | 315 | 118 | 266 | 226 |
营业收入 | 5752 | 4176 | 4378 | 5783 | 6602 |
利息收入(费用),非经营净值 | -541 | -425 | -379 | -676 | -938 |
其他,净值 | 306 | 144 | 56 | 90 | 11 |
税前净收入 | 5517 | 3895 | 4055 | 5197 | 5675 |
税后净收入 | 5061 | 3524 | 4743 | 4662 | 5377 |
少数股东权益 | -22 | -24 | -17 | -19 | 9 |
未计算非常项目前的净收益 | 5039 | 3500 | 4726 | 4643 | 5386 |
净收入 | 5039 | 3606 | 4789 | 4631 | 3104 |
普通股股东可获收益 (不含非经常性项目) | 5039 | 3500 | 4726 | 4643 | 5386 |
普通股股东可获收益 (含非經常性項目) | 5039 | 3606 | 4789 | 4631 | 3104 |
摊薄净收入 | 5039 | 3606 | 4789 | 4631 | 3104 |
摊薄后加权平均股 | 1351.4 | 1354 | 1351.1 | 1357.5 | 1368.2 |
扣除特别项目的每股摊薄盈利 | 3.72873 | 2.58493 | 3.49789 | 3.42026 | 3.93656 |
Dividends per Share - Common Stock Primary Issue | 2.52 | 2.32 | 2.16 | 2 | 1.84 |
每股正常摊薄盈利 | 4.58931 | 3.55835 | 4.13123 | 4.31147 | 3.82352 |
非常规项目总计 | 106 | 63 | -12 | -2282 | |
Total Adjustments to Net Income | 0 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
总收入 | 8089 | 7763 | 7847 | 7987 | 8188 |
收入 | 8089 | 7763 | 7847 | 7987 | 8188 |
收入成本,共计 | 2565 | 2433 | 2466 | 2507 | 2620 |
毛利 | 5524 | 5330 | 5381 | 5480 | 5568 |
总营业费用 | 6418 | 6104 | 6284 | 7128 | 6583 |
销售/一般/行政费用,总计 | 2570 | 2521 | 2579 | 2510 | 2348 |
研究与开发 | 652 | 668 | 676 | 750 | 632 |
Depreciation / Amortization | 435 | 432 | 431 | 436 | 446 |
异常费用(收入) | 53 | 113 | 111 | 833 | 338 |
Other Operating Expenses, Total | 143 | -63 | 21 | 92 | 199 |
营业收入 | 1671 | 1659 | 1563 | 859 | 1605 |
利息收入(费用),非经营净值 | -167 | -103 | -86 | -51 | -94 |
其他,净值 | 98 | 33 | 16 | 25 | 55 |
税前净收入 | 1602 | 1589 | 1493 | 833 | 1566 |
税后净收入 | 1492 | 1483 | 1317 | 769 | 1366 |
少数股东权益 | -6 | -4 | -6 | -6 | -6 |
未计算非常项目前的净收益 | 1486 | 1479 | 1311 | 763 | 1360 |
净收入 | 1486 | 1479 | 1311 | 763 | 1360 |
普通股股东可获收益 (不含非经常性项目) | 1485 | 1480 | 1311 | 763 | 1360 |
普通股股东可获收益 (含非經常性項目) | 1485 | 1480 | 1311 | 763 | 1360 |
摊薄净收入 | 1485 | 1480 | 1311 | 763 | 1360 |
摊薄后加权平均股 | 1343.9 | 1350.3 | 1355.3 | 1344.5 | 1357.9 |
扣除特别项目的每股摊薄盈利 | 1.10499 | 1.09605 | 0.96731 | 0.5675 | 1.00155 |
Dividends per Share - Common Stock Primary Issue | 0.63 | 0.63 | 0.63 | 0.63 | 0.58 |
每股正常摊薄盈利 | 1.05737 | 1.11753 | 1.06914 | 1.32317 | 1.38596 |
Total Adjustments to Net Income | -1 | 1 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流动资产总额 | 23059 | 22548 | 22031 | 21967 | 22980 |
现金和短期投资 | 10573 | 10817 | 10948 | 9848 | 11227 |
现金等价物 | 3714 | 3593 | 4140 | 4393 | 3669 |
短期投资 | 6859 | 7224 | 6808 | 5455 | 7558 |
应收账款总额,净额 | 5551 | 5462 | 4645 | 6222 | 5987 |
Accounts Receivable - Trade, Net | 5551 | 5462 | 4645 | 6222 | 5987 |
Total Inventory | 4616 | 4313 | 4229 | 3753 | 3579 |
Other Current Assets, Total | 2319 | 1956 | 2209 | 2144 | 2187 |
Total Assets | 90981 | 93083 | 90689 | 89694 | 91393 |
Property/Plant/Equipment, Total - Net | 6267 | 6219 | 5755 | 4675 | 4604 |
Property/Plant/Equipment, Total - Gross | 14219 | 13698 | 12571 | 10920 | 10259 |
Accumulated Depreciation, Total | -7952 | -7479 | -6816 | -6245 | -5655 |
Goodwill, Net | 40502 | 41961 | 39841 | 39959 | 39543 |
Intangibles, Net | 15595 | 17740 | 19063 | 20560 | 21723 |
Long Term Investments | 881 | 687 | 480 | 372 | 515 |
Other Long Term Assets, Total | 4677 | 3928 | 3519 | 2161 | 2028 |
Total Current Liabilities | 12394 | 8509 | 10366 | 8472 | 10084 |
Accounts Payable | 2276 | 2106 | 1996 | 1953 | 1628 |
Accrued Expenses | 5367 | 5681 | 4839 | 4885 | 5232 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3742 | 11 | 2776 | 838 | 2058 |
Other Current Liabilities, Total | 1009 | 711 | 755 | 796 | 1166 |
Total Liabilities | 38430 | 41655 | 39952 | 39603 | 40673 |
Total Long Term Debt | 20372 | 26378 | 22021 | 24486 | 23699 |
Long Term Debt | 20316 | 26316 | 21976 | 24476 | 23678 |
Capital Lease Obligations | 56 | 62 | 45 | 10 | 21 |
Deferred Income Tax | 884 | 1028 | 1174 | 1278 | 1423 |
Minority Interest | 171 | 174 | 135 | 121 | 102 |
Other Liabilities, Total | 4609 | 5566 | 6256 | 5246 | 5365 |
Total Equity | 52551 | 51428 | 50737 | 50091 | 50720 |
Common Stock | 0.13307 | 0.13454 | 0.13411 | 0.13407 | 0 |
Additional Paid-In Capital | 24566 | 26319 | 26165 | 26532 | 28127 |
Retained Earnings (Accumulated Deficit) | 30250 | 28594 | 28132 | 26270 | 24379 |
Unrealized Gain (Loss) | -209 | 92 | 0 | -45 | -194 |
Other Equity, Total | -2056.13 | -3577.13 | -3560.13 | -2666.13 | -1592 |
Total Liabilities & Shareholders’ Equity | 90981 | 93083 | 90689 | 89694 | 91393 |
Total Common Shares Outstanding | 1330.74 | 1345.4 | 1341.07 | 1340.7 | 1354.22 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
流动资产总额 | 23059 | 23303 | 22731 | 22434 | 22548 |
现金和短期投资 | 10573 | 11221 | 10669 | 10595 | 10817 |
现金等价物 | 3714 | 3479 | 2900 | 3004 | 3593 |
短期投资 | 6859 | 7742 | 7769 | 7591 | 7224 |
应收账款总额,净额 | 5551 | 5446 | 5493 | 5431 | 5462 |
Accounts Receivable - Trade, Net | 5551 | 5446 | 5493 | 5431 | 5462 |
Total Inventory | 4616 | 4514 | 4349 | 4288 | 4313 |
Other Current Assets, Total | 2319 | 2122 | 2220 | 2120 | 1956 |
Total Assets | 90981 | 91804 | 91756 | 91802 | 93083 |
Property/Plant/Equipment, Total - Net | 5413 | 5251 | 5188 | 5162 | 6219 |
Property/Plant/Equipment, Total - Gross | 13365 | 13074 | 12978 | 12808 | 12700 |
Accumulated Depreciation, Total | -7952 | -7823 | -7790 | -7646 | -7479 |
Goodwill, Net | 40502 | 41346 | 41612 | 41720 | 41961 |
Intangibles, Net | 15595 | 16078 | 16523 | 16890 | 17740 |
Long Term Investments | 881 | 827 | 781 | 692 | 687 |
Other Long Term Assets, Total | 5531 | 4999 | 4921 | 4904 | 3928 |
Total Current Liabilities | 12394 | 8927 | 7803 | 7764 | 8509 |
Accounts Payable | 2276 | 1985 | 1917 | 1864 | 2106 |
Accrued Expenses | 5672 | 5694 | 5403 | 5553 | 5681 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 3742 | 865 | 16 | 6 | 11 |
Other Current Liabilities, Total | 704 | 383 | 467 | 341 | 711 |
Total Liabilities | 38430 | 39262 | 39765 | 40316 | 41655 |
Total Long Term Debt | 20372 | 24290 | 25607 | 25958 | 26378 |
Long Term Debt | 20316 | 24232 | 25548 | 25898 | 26316 |
Capital Lease Obligations | 56 | 58 | 59 | 60 | 62 |
Deferred Income Tax | 884 | 968 | 1024 | 1054 | 1028 |
Minority Interest | 171 | 171 | 168 | 178 | 174 |
Other Liabilities, Total | 4609 | 4906 | 5163 | 5362 | 5566 |
Total Equity | 52551 | 52542 | 51991 | 51486 | 51428 |
Common Stock | 0.13307 | 0.13426 | 0.13449 | 0.13447 | 0.13454 |
Additional Paid-In Capital | 24566 | 25814 | 26059 | 26184 | 26319 |
Retained Earnings (Accumulated Deficit) | 30250 | 29607 | 28974 | 28511 | 28594 |
Unrealized Gain (Loss) | -209 | -22 | 48 | 104 | 92 |
Other Equity, Total | -2056.13 | -2857.13 | -3090.13 | -3313.13 | -3577.13 |
Total Liabilities & Shareholders’ Equity | 90981 | 91804 | 91756 | 91802 | 93083 |
Total Common Shares Outstanding | 1330.74 | 1342.57 | 1344.86 | 1344.67 | 1345.4 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 5062 | 3630 | 4806 | 4650 | 3095 |
经营活动产生的现金 | 7347 | 6240 | 7234 | 7007 | 4684 |
经营活动产生的现金 | 2707 | 2702 | 2663 | 2659 | 2644 |
Deferred Taxes | -604 | -422 | -1315 | -304 | -919 |
非现金物品 | 1070 | 1031 | 1019 | 1082 | 37 |
Cash Taxes Paid | 996 | 1250 | 878 | 1558 | 2542 |
已付现金利息 | 540 | 582 | 643 | 973 | 1147 |
营运资金的变化 | -888 | -701 | 61 | -1080 | -173 |
投资活动产生的现金 | -1659 | -2866 | -3203 | -774 | 5858 |
资本支出 | -1368 | -1355 | -1213 | -1134 | -1068 |
其他投资现金流量项目,总计 | -291 | -1511 | -1990 | 360 | 6926 |
融资活动产生的现金 | -5336 | -4136 | -4198 | -5431 | -11954 |
融资现金流项目 | 163 | -268 | -81 | 14 | -50 |
Total Cash Dividends Paid | -3383 | -3120 | -2894 | -2693 | -2494 |
股票的发行(报废),净额 | -2115 | -178 | -664 | -1885 | -1768 |
债务的发行(退还),净额 | -1 | -570 | -559 | -867 | -7642 |
外汇效应 | -231 | 215 | -86 | -78 | 114 |
现金净变化 | 121 | -547 | -253 | 724 | -1298 |
Apr 2022 | Jan 2022 | Oct 2021 | Jul 2021 | Apr 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 5062 | 3570 | 2086 | 769 | 3630 |
Cash From Operating Activities | 7347 | 5289 | 3061 | 1292 | 6240 |
Cash From Operating Activities | 2707 | 2019 | 1347 | 671 | 2702 |
Deferred Taxes | -604 | -234 | -78 | -11 | -422 |
Non-Cash Items | 1070 | 943 | 888 | 715 | 1031 |
Cash Taxes Paid | 996 | 842 | 615 | 249 | 1250 |
Cash Interest Paid | 540 | 295 | 280 | 63 | 582 |
Changes in Working Capital | -888 | -1009 | -1182 | -852 | -701 |
Cash From Investing Activities | -1659 | -1930 | -1493 | -784 | -2866 |
Capital Expenditures | -1368 | -979 | -649 | -378 | -1355 |
Other Investing Cash Flow Items, Total | -291 | -951 | -844 | -406 | -1511 |
Cash From Financing Activities | -5336 | -3387 | -2210 | -1055 | -4136 |
Financing Cash Flow Items | 163 | -52 | -46 | -4 | -268 |
Total Cash Dividends Paid | -3383 | -2540 | -1693 | -846 | -3120 |
Issuance (Retirement) of Stock, Net | -2115 | -794 | -470 | -204 | -178 |
Issuance (Retirement) of Debt, Net | -1 | -1 | -1 | -1 | -570 |
Foreign Exchange Effects | -231 | -87 | -51 | -42 | 215 |
Net Change in Cash | 121 | -115 | -693 | -589 | -547 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 9.3573 | 124491788 | 1243126 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.4559 | 72586912 | 3184703 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.512 | 60029051 | 1039338 | 2022-12-31 | LOW |
MFS Investment Management | Investment Advisor/Hedge Fund | 2.548 | 33898890 | 1194858 | 2022-12-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.2442 | 29857047 | -1240263 | 2022-12-31 | LOW |
Capital Research Global Investors | Investment Advisor | 2.1658 | 28814669 | 37199 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 2.0461 | 27222300 | 423715 | 2022-12-31 | LOW |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 1.2071 | 16059161 | 936343 | 2022-12-31 | LOW |
Managed Account Advisors LLC | Investment Advisor | 1.0987 | 14617260 | -3767415 | 2022-12-31 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.0919 | 14527410 | -214609 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.0274 | 13668496 | 626225 | 2022-12-31 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 0.9969 | 13263284 | 1797223 | 2022-12-31 | LOW |
Sanders Capital, LLC | Investment Advisor | 0.9515 | 12658542 | -199168 | 2022-12-31 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.9013 | 11990457 | 545538 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.8866 | 11794893 | -258903 | 2022-12-31 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7999 | 10641725 | 2548341 | 2022-12-31 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.7763 | 10328189 | 1336047 | 2022-12-31 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 0.7543 | 10034945 | 194817 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7234 | 9624338 | -453649 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.7002 | 9315796 | 255281 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Medtronic Company profile
关于 Medtronic PLC
美敦力公司是一家全球医疗技术公司。 它开发、制造并向医院、医生、临床医生和病人销售其医疗设备和技术。 它的运营部门包括心血管、医疗外科、神经科学和糖尿病。 心血管产品包括心脏起搏器、可插入式心脏监测器和心脏再同步化治疗设备。 内科手术产品包括从诊断到康复的病人护理,重点是胃肠道、肺、盆腔、肾脏、肥胖症和可预防的并发症等疾病。 神经科学产品包括各种脊柱植入物、骨移植替代物、生物制品、图像引导手术和术中成像系统。 糖尿病产品包括胰岛素泵、连续血糖监测(CGM)系统、消耗品和智能胰岛素笔系统。 公司还提供PROPEL和SINUVA,这是用于鼻窦患者的生物吸收、类固醇洗脱的植入物。
Industry: | Medical Equipment, Supplies & Distribution (NEC) |
20 On Hatch
Hatch Street Lower
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。